AMPA GluA1-flip targeted oligonucleotide therapy reduces neonatal seizures and hyperexcitability.

Lykens NM, Coughlin DJ, Reddi JM, Lutz GJ, Tallent MK

Open source

DOI
10.1371/journal.pone.0171538
Published
2017
Container
PloS one
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1371/journal.pone.0171538,
  title = {AMPA GluA1-flip targeted oligonucleotide therapy reduces neonatal seizures and hyperexcitability.},
  author = {Lykens NM and Coughlin DJ and Reddi JM and Lutz GJ and Tallent MK},
  year = {2017},
  journal = {PloS one},
  doi = {10.1371/journal.pone.0171538},
  url = {https://doi.org/10.1371/journal.pone.0171538}
}

RIS

TY  - JOUR
TI  - AMPA GluA1-flip targeted oligonucleotide therapy reduces neonatal seizures and hyperexcitability.
AU  - Lykens NM
AU  - Coughlin DJ
AU  - Reddi JM
AU  - Lutz GJ
AU  - Tallent MK
PY  - 2017
JO  - PloS one
DO  - 10.1371/journal.pone.0171538
UR  - https://doi.org/10.1371/journal.pone.0171538
ER  - 

APA

NM, L., DJ, C., JM, R., GJ, L., & MK, T. (2017). AMPA GluA1-flip targeted oligonucleotide therapy reduces neonatal seizures and hyperexcitability.. PloS one. https://doi.org/10.1371/journal.pone.0171538

Source records